Associations Between Coronary Artery Calcium Score and Exacerbation Risk in BLOCK-COPD

R Chad Wade1,2,3,4, Sharon X Ling5, Erika S Helgeson5

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.

Insights

Coronary artery calcium (CAC) scores did not predict exacerbation risk in chronic obstructive pulmonary disease (COPD) patients. However, CAC in the left circumflex artery showed a novel association with increased exacerbation risk.

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) is a common comorbidity in patients with chronic obstructive pulmonary disease (COPD), contributing to significant mortality.
  • The Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (BLOCK-COPD) study investigated metoprolol's effect on exacerbations in COPD patients without beta-blocker indications.

Purpose of the Study:

  • To evaluate if coronary artery calcium (CAC) score, an imaging metric for CAD, predicts exacerbation risk in COPD patients.
  • To determine if CAC score identifies a differential response to metoprolol treatment in this population.

Main Methods:

  • Utilized data from the BLOCK-COPD study, including participants who underwent thoracic computed tomography (CT) scans.
  • Quantified CAC scores using the Weston scoring system and analyzed associations with time to exacerbation using adjusted Cox proportional hazards models.

Main Results:

  • In 109 participants, 84% had detectable CAC. Over a median follow-up of 350 days, 61 mild and 19 severe exacerbations occurred.
  • No significant associations were found between overall CAC burden and exacerbation risk.
  • A novel association was observed between CAC in the left circumflex (LCx) artery and increased risk of any-severity exacerbation (aHR=1.39, p=0.01 for total CAC; aHR=1.96, p=0.04 for CAC>0).

Conclusions:

  • While CAC score confirms high CAD prevalence in COPD, it did not predict overall exacerbation risk in this cohort.
  • Novel associations between LCx CAC and exacerbation risk warrant further investigation in larger COPD populations.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
18
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
12
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
302